Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -89.941% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) CCOc1ccc(OCC)c(NC(=O)C2CCCN(S(=O)(=O)c3cccnc3)C2)c1
b.) CC(CCOS(N)(=O)=O)c1ccccc1
c.) Fc1ccc(-n2cc(CNCCc3ccccn3)c(-c3ccccc3Cl)n2)cc1
d.) O=C(O)CS(=O)(=O)c1ccc(Oc2ccc(S(=O)(=O)CC(=O)O)cc2)cc1
e.) CCOc1ccccc1N/C=C(\C#N)c1nc2ccccc2n1C
Answer: c. Fc1ccc(-n2cc(CNCCc3ccccn3)c(-c3ccccc3Cl)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Fc1ccc(-n2cc(CNCCc3ccccn3)c(-c3ccccc3Cl)n2)cc1
Fc1ccc(-n2cc(CNCCc3ccccn3)c(-c3ccccc3Cl)n2)cc1
N-[[3-(2-chlorophenyl)-1-(4-fluorophenyl)pyrazol-4-yl]methyl]-2-pyridin-2-ylethanamine